Annual Drug Patent Expirations for TYRVAYA
Tyrvaya is a drug marketed by Oyster Point Pharma and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has thirty-two patent family members in eighteen countries.
The generic ingredient in TYRVAYA is varenicline tartrate. One supplier is listed for this compound. Additional details are available on the varenicline tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
